The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada
Uloženo v:
Franklyn, A.M., et al., The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada. International Journal of Drug Policy, vol. 48, 2017, p. 1-8.
Ref.
527850
Umístění:
SIIS Archivo (R.1114)
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Cocaína, Tratamiento médico, Programas de mantenimiento, Reducción de daños, Recaída, Metadona, Buprenorfina, Canadá
Drogodependencias, Drogas ilegales, Opiáceos, Cocaína, Tratamiento médico, Programas de mantenimiento, Reducción de daños, Recaída, Metadona, Buprenorfina, Canadá
Podobné jednotky: The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada
- The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
- MULTIMODAL DRUG ADDICTION TREATMENT: A FIELD COMPARISON OF METHADONE AND BUPRENORPHINE AMONG HEROIN- AND COCAINE-DEPENDENT PATIENTS
- OPIOID AGONIST PHARMACOTHERAPY IN NEW SOUTHWALES FROM 1985 TO 2006: PATIENT CHARACTERISTICS AND PATTERNS AND PREDICTORS OF TREATMENT RETENTION
- Interim opioid agonist treatment for opioid addiction: a systematic review
- Comparing Canadian and United States opioid agonist therapy policies
- Study on users' perception of agonist opioid treatment in the Galician network of drug addiction